In 2016, the global superdisintegrants market was worth approximately USD 258.6 millions. It is forecast to grow at 7.2% CAGR over the forecast period. The market's growth is driven by factors such as the growing generic drug market, the geriatric and children population who have difficulties swallowing tablets/capsules, and the development of superdisintegrants that will be used in the pharmaceutical industry.
Moreover, the increasing global pharmaceutical consumption is driving the demand for superdisintegrants. Pharmaceuticals account for 20% of total health expenditure in Organization for Economic Co-operation and Development countries (OECD), with Canada being the highest pharmaceutical spender.
U.S. superdisintegrants market revenues, by product (2014 - 2025, USD Million)
In 2016, Crospovidone was the dominant product in this segment. Crospovidone is able to stabilize the amorphous drug state due to its inhibition of drug recrystallization, and rapid solidification rate. Crospovidone is also known for its excellent disintegration-enhancing and dissolution-enhancing properties, which are used in preparation of capsules, tablets, granules and granules. These factors will all contribute to the segment's growth during the forecast period.
The highest expected CAGR for the other segment, which includes natural superdisintegrants like Isapghula, gellan gum and locust bean, is however, predicted to be the others segment. Due to its high hydrophilic properties, it has immediate swelling characteristics that cause tablets to swell when in contact with water. Researchers are constantly looking for new disintegrating agents to replace these superdisintegrants. This includes the testing of modified natural products such as chitin and chitosan, polymerized acrylicamide, xylems, cross-linked carbonoxymethyl guar, modified tapioca starch, and chitin.
In 2016, the market was dominated by capsules and tablets. Tablets are more cost-effective, have a longer shelf life and can be accurately dosed. The most important excipient in tablet and capsule formulations are disintegrants. They are used to cause the tablets to break apart when they come into contact with aqueous liquid. The FDA has approved tablets and capsules with a quick-dissolving dosage forms. These products are included in the approved drug products with therapeutic equivalent evaluations. This would increase the growth of this segment. Starch (and its derivatives), Crospovidone and cellulose are some of the disintegrants that are used in multifunctional tablet or capsule formulations.
The fastest growth is expected in the Mouth-dissolving Film segment during the forecast period. The growth of this segment is due to its unique advantages and properties, large surface area that can quickly dissolve and dissolve in the oral cavity, precise dosing, fast onset of action and better patient compliance.
Market revenue for global superdisintegrants by product in 2016, (%)
North America was the dominant superdisintegrants market, accounting for the highest revenue share in 2016. The market's top drivers include the increasing demand for generic drugs and better manufacturing techniques. North America also has some of the largest players in the superdisintegrants market.
Asia Pacific will experience the fastest growth over the forecast period. Asia Pacific is expected to see growth due to factors such as increased outsourcing of superdisintegrants and new superdisintegrants manufacturing, and the adoption of novel technologies (novel drugs delivery system).
The superdisintegrants industry is fragmented and has a few players. Ashland Global Holdings Inc. and Roquette Freres S.A. are some of the leading companies in this sector. The Dow Chemical Company, BASF SE. These companies will increase their market share through strategic initiatives such as mergers, acquisitions and regional expansion.
This report provides a forecast of revenue growth at the global, regional and country levels. It also analyzes the most recent trends and opportunities in each sub-segment from 2014-2025. Up Market Research has divided the global superdisintegrants industry by product, dosage form, region, and purpose.
Product Outlook (Revenue USD Million, 2014-2025)
Croscarmellose sodium
Crospovidone
Sodium starch glycolate
Ion exchange resin
Other
Outlook for Dosage Form (Revenue, USD million, 2014-2025)
Tablets and capsules
Films that dissolve the mouth
Regional Outlook (Revenue USD Million, 2014-2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
Japan
China
Latin America
Brazil
Mexico
MEA
South Africa
b. Global superdisintegrants market was valued at USD 324.9 Million in 2019, and is projected to grow to 349.2 Million in 2020.
What is the market growth for superdisintegrants?b. Global superdisintegrants are expected to grow at 7.2% compound annual growth rate from 2017 to 2025, to reach USD 487 millions by 2025.
Which market segment had the largest share of superdisintegrants?b. With a 29.3% share in 2019, North America dominated superdisintegrants. This can be attributed to the increasing demand for generic medicines and the presence of large players in the region.
What are the major players in the superdisintegrants marketb. Ashland Global Holdings Inc. and Roquette Freres are some of the key players in superdisintegrants.
What are the driving factors for the superdisintegrants industry?b. Market growth is driven by the growing market for generic drugs, the emergence of novel superdisintegrants and the booming industry in emerging countries.
Up Market Research published a new report titled “Superdisintegrants Market research report which is segmented by Dosage Form (Capsules, Mouth-dissolving Films, Tablets), by Product (Ion exchange resin, Crospovidone, Sodium starch glycolate, Croscarmellose sodium), By Players/Companies Roquette Fr¨res, Corel Pharma Chem, DowDuPont Inc, DFE Pharma, Merck KGaA, Ashland Global Holdings Inc, BASF SE, JRS Pharma”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Superdisintegrants Market Research Report |
By Dosage Form | Capsules, Mouth-dissolving Films, Tablets |
By Product | Ion exchange resin, Crospovidone, Sodium starch glycolate, Croscarmellose sodium |
By Companies | Roquette Fr¨res, Corel Pharma Chem, DowDuPont Inc, DFE Pharma, Merck KGaA, Ashland Global Holdings Inc, BASF SE, JRS Pharma |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 246 |
Number of Tables & Figures | 173 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Dosage Form (Capsules, Mouth-dissolving Films, Tablets), by Product (Ion exchange resin, Crospovidone, Sodium starch glycolate, Croscarmellose sodium).
Superdisintegrants Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Superdisintegrants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Superdisintegrants Market Report:
Some other reports from this category!